Resonance Health Limited
Resonance Health Limited
- P/E ratio
- 23.75
Your view on RHT.AX
Overview
What the company does, where it operates, and who runs it.
About Resonance Health Limited
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Andrew Duncan Harrison
- Headquarters
- 141 Burswood Road, Burswood, WA, AU
- Industry
- Medical - Healthcare Information Services
- Sector
- Healthcare
- CEO
- Andrew Duncan Harrison
- Headquarters
- 141 Burswood Road, Burswood, WA, AU
Resonance Health Limited is a global provider of healthcare technology and services, specializing in the design, development, and production of software-as-medical devices. The company serves markets across the Asia Pacific, Americas, Europe, Middle East, and Africa.
Its portfolio of non-invasive, MRI-based diagnostic tools includes FerriScan, a system for quantifying liver iron concentration (LIC); FerriSmart, leveraging artificial intelligence (AI) for automated, real-time assessment of LIC; HepaFat-AI, an AI-driven solution for real-time, multi-metric liver fat quantification; CardiacT2, which provides dual analysis in conjunction with FerriScan to evaluate cardiac iron accumulation; HepaFat-Scan, a non-invasive MRI method for assessing liver fat within tissue; and LiverSmart, a comprehensive non-invasive MRI device integrating FerriSmart and HepaFat-AI for a unified report.
The company further extends its offerings to include quantitative imaging measurements and Contract Research Organization (CRO) services, encompassing rigorous image analysis, imaging charter development, robust project and data management, proactive issue resolution, site tracking with clinical trial progress reports, and streamlined data flow coordination.
They also provide comprehensive biomarker services, covering analysis of blood, urine, and protein analytes, alongside RNA, DNA, and genotyping.
Their support for multinational and multicenter clinical trials extends to protocol development, subject inclusion/exclusion criteria assessment, dose modification strategies, new therapy safety profile evaluations, and establishing primary and secondary endpoints for drug efficacy.
Additionally, they supply phantoms crucial for MRI machine calibration. Its client base includes clinicians, who utilize their solutions for managing human diseases, and pharmaceutical and therapeutic companies engaged in clinical research. Established in 1987, Resonance Health Limited maintains its headquarters in Burswood, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Resonance Health Limited. Starting points for Resonance Health Limited: P/E 23.8, beta 1.08 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Resonance Health Limited. Resonance Health Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Resonance Health Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Resonance Health Limited. Resonance Health Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AT1.AXAtomo Diagnostics Limited | Healthcare | Medical - Devices | — | ||
| ENL.AXEnlitic, Inc. | Healthcare | Medical - Healthcare Information Services | — | ||
| HMD.AXHeraMED Limited | Healthcare | Medical - Devices | — | ||
| ICR.AXIntelicare Holdings Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| IDT.AXIDT Australia Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IMC.AXImmuron Limited | Healthcare | Biotechnology | — | ||
| IME.AXImExHS Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| HTFLHeartflow, Inc. Common Stock | Healthcare | NASDAQ | $4.0B | ||
| IBXGiBX Group, Inc. | Healthcare | OTC | $1,975 | ||
| ICCOInterCare DX, Inc. | Healthcare | OTC | $1,990 | ||
| IGRWInteractive Health Network | Healthcare | OTC | $39,815 | ||
| LFCOFLift & Co. Corp. | Healthcare | OTC | $71,601 | ||
| LFMDLifeMD, Inc. | Healthcare | NASDAQ | $82.2M | ||
| LFMDPLifeMD, Inc. | Healthcare | NASDAQ | $131.2M | ||
| LVCELiveCare, Inc. | Healthcare | OTC | $381,860 | ||
| LYNX.CNLynx Global Digital Finance Corporation | Healthcare | CNQ | $6.4M | ||
| M7T.AXMach7 Technologies Limited | Healthcare | ASX | — | ||
| MDBIFTrivarX Limited | Healthcare | OTC | $1.6M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Resonance Health Limited. Coverage tracks Resonance Health Limited within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Resonance Health Limited.